Hashem Taha

Building and investing in enterprise AI, bio, healthtech, & computational sciences.

📍 Canada🔄 Updated September 2026💼 16 investments📅 9 years investing🗓 Last invested Jun 2025
VC🌍 Canada
16
Total investments
5
Early stage
3
Mid stage
5
Late stage
9y
Years active

Portfolio

16 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Capital Formation and Investments
Jun 2025
This is the biology century. Software changed the world over the last 30 years. Technology and biology will converge over the next 30 to have an even larger impact. We focus on four key verticals: 1) Artificial Intelligence: therapeutic development platforms, diagnostic and decision support, workflow and insurance, and predictive analytics. 2) Longevity: early screening and intervention, preventative care, remote patient monitoring and care, and integrated care platforms. 3) Data-driven care: value-based care, real world data / evidence, payment integrity, and sustainable healthcare models. 4) Deep technology: synthetic biology, nanotechnology, personalized medicine, and genomics.
Investor
Jun 2022
Reach is the leader in high-performance wireless power-at-a-distance. Reach’s wireless power solution does for power delivery what Wi-Fi does for data connectivity. The Reach system is built on state-of-the-art, patented technology, including high-efficiency power beaming circuits, network optimization algorithms, and adaptive electromagnetic surfaces, delivering a highly scalable, safe, and easy-to-use power platform. Ideally suited for critical infrastructure, government, energy, logistics, and first responders, the Reach solution provides flexible access to power where and when needed, streamlining device deployment and improving device performance.
Investor
May 2022
Decoding Secreted Proteins for Chronic and Age-Related Diseases
Investor
Apr 2022
NFW is a circularity platform for plastic-free performance materials. NFW follows three Ground Rules in everything we develop: start well, stay clean, end well. While nearly everything in the built world relies on some type of plastic that began as crude oil and that will become plastic pollution, we are establishing a new material reality. We believe all materials should begin and end as nutrients, ready for the next growth cycle—true circularity. Our multi-material platform serves a wide range of industries—from fashion and footwear to automotive and upholstery. NFW technology embeds seamlessly into existing supply chains, enabling the world’s most iconic brands to design and scale products with high-performance, plastic-free materials. NFW makes global brands more sustainable, empowering them to create without plastics. Alongside the boldest brands and visionary designers, we are pioneering a naturally circular, post-oil economy.
Investor
Jan 2022
Vectara developed an integrated AI Assistant/Agent solution which focuses on enterprise readiness, especially when it comes to: Accuracy (eliminating "Hallucinations"), explainability of results/actions, and secure access control. More technically, under the hood Vectara provides a serverless end-to-end Retrieval-Augmented-Generation (RAG for short) platform which combines multi-lingual hybrid (semantic+lexical) information retrieval with AI-generated responses/actions while giving developers the optionality to optimize its behavior vs messing around with its guts (analogous to giving a database a hint to change join strategy versus changing the join algorithm manually). Enterprise customers and technology partners embed Vectaras GenAI platform in their own applications through easy plug-n-play API integrations vs re-inventing the wheel by building their own do-it-yourself solutions (which are hard to maintain overtime as the models underneath keep evolving rapidly). To top it off, there is a strong focus on solution testability, scalability, reliability, availability, resilience to prompt attacks, copyright protection, and bias mitigation, ensuring that applications built on top of Vectara are trustworthy for the enterprise.
Investor
Aug 2021
We aim to solve the energy delivery challenge for electric transportation by utilizing autonomous robotics and smart-battery technology. Weve created an economical, rapidly deployable and widely accessible platform that delivers a full charge to any electric car in minutes. The aim is to make it possible to have “Electric Cars for Everyone”.
Investor
Mar 2021
Eat Just is a food technology company with a mission to build a healthier, safer and more sustainable food system in our lifetimes. The company’s expertise, from functionalizing plant proteins to culturing animal cells, is powered by a world-class team of scientists and chefs spanning more than a dozen research disciplines. Eat Just created America’s fastest-growing egg brand, which is made entirely of plants, and the world’s first-to-market meat made from animal cells instead of slaughtered livestock.
late stageFood Production
Investor
Jan 2021
DevSecOps Automation Platform to Secure your Software Supply Chain
Investor
Aug 2020
As a pioneer in democratizing artificial intelligence, aiXplain provides businesses with innovative tools to swiftly build, deploy, and scale AI solutions. Their integrated suite of tools and AI assets, such as models, datasets, and pipelines, make sophisticated AI-based application development accessible to all levels of an organization. With data at the core, aiXplain tools create custom solutions to align with business needs. Committed to excellence and guided by a vision for the future of AI, aiXplain fuels the development of the next generation of intelligent business applications.
Investor
Aug 2020
Modern Meadow is focused on creating innovative biomaterials that make a positive impact on the world. Its main product, BIO-VERA®, is a transformative new sustainable material that is not only beautiful, but stronger and lighter than traditional materials. Made with over 80% renewable carbon content, BIO-VERA is crafted using BIO-ALLOY®, a flexible mix of proteins and polymers. This approach allows Modern Meadow to reduce reliance on oil-based and animal products without sacrificing quality. BIO-VERA is designed to easily integrate into existing production processes used by industries such as automotive, footwear, furniture and fashion accessories, making it a practical option for immediate use. Modern Meadow works closely with top brands like Tory Burch and industry leaders like BASF, Bader and ISA TanTec to ensure its products are of the highest quality and fully traceable from its lab to the brands people love. For more information, visit modernmeadow.com or follow the company on LinkedIn and Instagram. We are always open to connecting with strong talent and invite interested individuals to learn more by visiting the careers page of our website.
Investor
Jan 2020
A minority owned venture studio, advisory and VC investment firm. We are based in San Francisco, and identify early, overlooked or dismissed talent from outside Silicon Valley, with special attention to Black, female and Middle Eastern founders and help them crack Silicon Valley in weeks instead of months or years on their own. We like to back resilient, ambitious driven founders who are building technology startups that are truly defensible, which we define as having deep technology moats with strong network effects. The ingredients for building truly transformative companies that can impact billions! Founders are welcome to reach out to us anytime here https://transform.vc/founders/
Investor
Feb 2019
We’re rethinking everything. Starting with food. Using safe, proven fermentation methods we make animal-free whey protein from microflora – not cows – to make dairy that’s identical to traditional milk. The production of our whey protein emits up to 97% less greenhouse gas emissions, uses up to 99% less blue water, and uses up to 60% less nonrenewable energy, compared to the production of protein found in traditional milk. Our protein comes in a variety of applications including cream cheese, barista milk, ice cream, protein powder, egg replacer, bakery mix, confectionery, and gelato. Some of our partners in-market include Mars, Nestlé, Natreve, Brave Robot, Myprotein, Strive Nutrition, Nicks, Tomorrow Farms, Villa Dolce, Betterland, and more. It’s dairy that’s better for everything.
Investor
Jul 2018
Through LeoLabs Vertex™, our vertically integrated space operations stack, we’re transforming the way satellite operators, commercial enterprises, and federal agencies launch and track missions in low Earth orbit. With unmatched coverage, real-time tracking, and powerful insights, companies and governments around the world rely on us to safely execute operations in space.
Investor
Jun 2018
Kneron, a leading provider of edge AI solutions, was founded in 2015 at San Diego, US. It is dedicated to design and development of integrated software and hardware edge AI solutions. Barely two years old, Kneron already has partners and customers around the world, and has provided customized solutions for home appliances, surveillance systems, and smartphones to several international companies. Kneron announced the completion of series A financing at over ten million US dollars on November, 2017. Alibaba Entrepreneurs Fund and CDIB Capital Group are the lead investors, and Himax Technologies, Inc., Qualcomm, Thundersoft, Sequoia Capital (its sub funds: Cloudatlas), and CY ZONE are co-investors. Kneron are cooperating with its strategic partners to promote the edge AI technologies and speed up the popularity of AI applications.
Show all 16 investments ↓
Experience · 18 entries
All (18)
Investments (16)
2025
Capital Formation and Investments
Jun 2025
This is the biology century. Software changed the world over the last 30 years. Technology and biology will converge over the next 30 to have an even larger impact. We focus on four key verticals: 1) Artificial Intelligence: therapeutic development platforms, diagnostic and decision support, workflow and insurance, and predictive analytics. 2) Longevity: early screening and intervention, preventative care, remote patient monitoring and care, and integrated care platforms. 3) Data-driven care: value-based care, real world data / evidence, payment integrity, and sustainable healthcare models. 4) Deep technology: synthetic biology, nanotechnology, personalized medicine, and genomics.
2023
Entrepeneur in Residence & Venture Creation
Jan 2023
Related Sciences (RS) is a data science-driven drug discovery firm. RS invests in and leads the discovery of valuable preclinical medicines utilizing a specialized new model designed from the ground up to improve capital efficiency, operational scalability, and deliver superior risk-adjusted returns. RS uses a proprietary AI/ML platform to identify the best new opportunities for every disease, assembles large decentralized teams of field-leading researchers to guide world-class science, and then leads efficient, multi-modality drug discovery via preclinical-specialized staff and R&D platforms. The RS mission is to deliver a new biotech investment paradigm with a significantly improved risk-reward profile to accelerate the creation of transformative new medicines for patients, and to materially broaden the sector’s investor appeal. RS was founded by a multi-disciplinary team of drug discovery, data science, and private equity veterans who have built and led biotech companies worth billions and is backed by a luminary group of investors. www.related.vc
2022
Investor
Jun 2022
Reach is the leader in high-performance wireless power-at-a-distance. Reach’s wireless power solution does for power delivery what Wi-Fi does for data connectivity. The Reach system is built on state-of-the-art, patented technology, including high-efficiency power beaming circuits, network optimization algorithms, and adaptive electromagnetic surfaces, delivering a highly scalable, safe, and easy-to-use power platform. Ideally suited for critical infrastructure, government, energy, logistics, and first responders, the Reach solution provides flexible access to power where and when needed, streamlining device deployment and improving device performance.
Investor
May 2022
Decoding Secreted Proteins for Chronic and Age-Related Diseases
Show all 18 entries ↓
Investment activity
2017–2025 · 16 investments
20171201822019120203202132022520251
Recent (last 2 years)Earlier